Taking a more long-term approach, HCP had a 52-week range of $24.47 to $36.73. At the time of this article’s publishing, this stock is trading at $36.45 after starting the trading session at $36.57. At the time of writing, this stock’s 50-day Moving Average stands at $34.68, while the 200-day Moving Average of this stock is currently $31.84.
Currently, this company’s share volume is sitting at $2274099, but has maintained average daily volume of $2.75M. This stock has generated an average Year to Date volume of $3.01 million, alongside an average 20-day volume of $3.2 million. This publicly-traded company’s shares outstanding now amounts to $488.41 million, simultaneously with a float of $488.41 million. The organization now has a market capitalization sitting at $17.80 billion.
HCP Inc.(HCP) Ownership Data
Now let’s turn our focus to how large-scale investors are behaving with this stock. HCP Inc.’s current insider ownership accounts for 0.10%, in contrast to 98.40% institutional ownership. According to the most recent latest insider trade that took place on Sep 04 this organization’s EVP, CDO and COO exercised an option 35,014 at the rate of 24.67, making the entire transaction hit 863,795 in total value, affecting insider ownership by 230,529. Preceding that transaction, on Sep 04 Company’s EVP, CDO and COO sold 35,014 at a price of 36.02, making the whole transaction’s value amount to 1,261,215. This particular insider is now the holder of 195,515 in total.
If we take a glance at the Ownership summary of HCP Inc.’s stock, Institutional holders make up 98.40% of its total stock ownership. All together, they are the legal holders of 488.41M shares. If we focus on the top 3 stockholders for this publicly-traded organization, The Vanguard Group, Inc. owns 77,475,300 shares, with SSgA Funds Management, Inc. in 2nd place owning 35,093,363 shares and BlackRock Fund Advisors in third place with total ownership of 32,402,093 shares.
HCP Inc. (HCP) Earnings and Revenue Data
In the latest quarterly report that this company released, which was put into the public domain on 6/29/2019, the organization reported -$0.03 earnings per share (EPS) for the three-month period, surpassing the consensus estimate (set at $0.13) by -$0.16.
This company achieved a net margin of 55.37 while generating a return on equity of 17.4. HCP Inc.’s full-quarter revenue increased by 16.35%, when compared against the year-ago quarter. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.09 per share during the current fiscal year.
HCP Inc.’s EPS increase for this current 12-month fiscal period is 144.40%, and is forecasted to reach 0.41 in the upcoming year. Looking at the long run, market analysts have predicted that Company’s EPS will increase by 2.50% through the next 5 years, which can be compared against the 2.70% growth it accomplished over the previous five years trading on the market.
Additional Trading Performance Indicators
The company has managed to achieve an average true range (ATR) of 0.58. Alongside those, its PE Ratio stands at $18.13, and its Beta score is 0.20.
Another valuable indicator worth considering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 9.75 for this organization. Plus, this company’s price to book ratio for the last three-month fiscal period reported is 2.88, whereas its price to cash per share for the last quarter landed at 0.27.
In the same vein, HCP’s Diluted EPS (Earnings per Share) trailing twelve months was posted at 2.01, a figure that is expected to reach 0.05 in the next reported quarter, and analysts expect it will be 0.41 at the market close of one year from today’s date.